School of Medicine
Showing 901-928 of 928 Results
Joseph C. Wu
Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor and Professor of Radiology
Current Research and Scholarly Interests Drug discovery, drug screening, and disease modeling using biobank of cardiac iPSC lines.
Associate Professor of Medicine (Endocrinology)
Current Research and Scholarly Interests My laboratory focuses on the pathways that regulate the differentiation of mesenchymal stem cells into the osteoblast and adipocyte lineages. We are also studying the role of osteoblasts in the hematopoietic and cancer niches in the bone marrow microenvironment.
Sean M. Wu
Associate Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Pediatrics
Current Research and Scholarly Interests My lab seeks to identify mechanisms regulating cardiac lineage commitment during embryonic development and the biology of cardiac progenitor cells in development and disease. We believe that by understanding the transcriptional and epigenetic basis of cardiomyocyte growth and differentiation, we can identify the most effective ways to repair diseased adult hearts. We employ mouse and human embryonic and induced pluripotent stem cells as well as rodents as our in vivo models for investigation.
Adjunct Professor, Medicine - Primary Care and Population Health
Bio Dr. Jiayin Xue joined the Stanford Clinical Excellence Research Center (CERC) in 2019. Currently, she advises and supports CERC in educational, research, fundraising, and partnership efforts relevant to her unique industry background. Prior to joining CERC, she was a management consultant engaged in organizational strategy work across a number of sectors including healthcare, social impact, and financial services. She completed her pediatrics residency training at the Massachusetts General Hospital and currently practices clinically at The Permanente Medical Group.
Dr. Jiayin Xue received her M.D. degree from the University of North Carolina at Chapel Hill and her M.P.H. degree with a concentration in Quantitative Methods from the Harvard School of Public Health. She also received her B.S. with Highest Distinction and Highest Honors in Chemistry and minors in English and Biology from the University of North Carolina at Chapel Hill.
Phillip C. Yang, MD
Associate Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Yang is a physician-scientist whose research interest focuses on clinical translation of the fundamental molecular and cellular processes of myocardial restoration. His research employs novel in vivo multi-modality molecular and cellular imaging technology to translate the basic innovation in cardiovascular pluripotent stem cell biologics. Dr. Yang is currently a PI on the NIH/NHLBI funded CCTRN UM1 grant, which is designed to conduct multi-center clinical trial on novel biological therapy.
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Bio Seema Yasmin is an Emmy Award-winning journalist, poet, medical doctor and author. Yasmin served as an officer in the Epidemic Intelligence Service at the U.S. Centers for Disease Control and Prevention where she investigated disease outbreaks and was principal investigator on a number of CDC studies. Yasmin trained in journalism at the University of Toronto and in medicine at the University of Cambridge.
Yasmin was a finalist for the Pulitzer Prize in breaking news in 2017 with a team from The Dallas Morning News and recipient of an Emmy for her reporting on neglected diseases. She received two grants from the Pulitzer Center on Crisis Reporting. In 2017, Yasmin was a John S. Knight Fellow in Journalism at Stanford University investigating the spread of health misinformation and disinformation during epidemics. Previously she was a science correspondent at The Dallas Morning News, medical analyst for CNN, and professor of public health at the University of Texas at Dallas.
Her writing has earned awards and residencies from the Mid Atlantic Arts Council, Hedgebrook, the Millay Colony for the Arts and others. Her first book, The Impatient Dr. Lange (Johns Hopkins University Press, July 2018) is the biography of an AIDS doctor killed on Malaysia Airlines flight MH17. Her second book, Debunked! Pseudoscience, Medical Myths and Why They Persist, is forthcoming in November 2019. A major title about women is forthcoming from HarperCollins in 2020.
Yasmin?s unique expertise in medicine, epidemics and journalism has been called upon by The Presidential Commission for the Study of Bioethical Issues, the Aspen Institute, Skoll Foundation and others.
Instructor, Medicine - Primary Care and Population Health
Bio Maria Yefimova PhD RN is a nurse researcher working to address disability, social and palliative needs of older patients and support their caregivers in the home and community-based settings. Her research focuses on emergent technological solutions, such as remote health monitoring and predictive analytics.
She is a health services researcher with the HSR&D Center for Innovation to Implementation (Ci2i) at VA Palo Alto Healthcare System. She also has a position with the Office of Research, Patient Care Services at Stanford Healthcare. Dr. Yefimova earned her Bachelor?s, Master?s and PhD degrees in Nursing from the University of California, Los Angeles (UCLA). She completed her post-doctoral fellowship in the National Clinician Scholars Program at UCLA, among the first nurses to receive health services research training alongside physicians in the legacy of Robert Wood Johnson Foundation (RWJF) Clinical Scholars Program.
Sr Research Scholar, Medicine - Family & Community Medicine
Current Research and Scholarly Interests Ethnicity and Dementia
Alan Yeung, MD
The Li Ka Shing Professor in Cardiology
Current Research and Scholarly Interests Coronary artery disease is the leading cause of death in men and women in the United States. Our group is interested in studying both the early and late phases of atherosclerosis so that we can better develop prevention and treatment strategies.
Paul Yock, MD
The Martha Meier Weiland Professor in the School of Medicine, Professor of Bioengineering and, by courtesy, of Mechanical Engineering
Current Research and Scholarly Interests Health technology innovation using the Biodesign process: a systematic approach to the design of biomedical technologies based on detailed clinical and economic needs characterization. New approaches for interdisciplinary training of health technology innovators, including processes for identifying value opportunities in creating new technology-based approaches to health care.
Assistant Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center
Bio Celina Yong, MD, MBA, MSc is Director of Interventional Cardiology at the Palo Alto VA Medical Center and an Assistant Professor in the Division of Cardiovascular Medicine at Stanford. Dr. Yong completed her medical training at Stanford School of Medicine and her internal medicine residency at the University of California, San Francisco. She completed her cardiology and interventional cardiology fellowships at Stanford, including a year as Chief Fellow. As a Marshall Scholar, she completed a Masters in Health Policy, Planning and Financing from the London School of Economics and an MBA from Oxford.
Dr. Yong?s current research focuses on understanding and innovating scalable technologies to reduce inequities in cardiovascular care for patients. Specifically, she is interested in understanding and resolving racial, gender, geographic, and socioeconomic disparities in access to high quality minimally invasive treatments, as well as gender imbalances in the medical profession itself. She is also actively involved in clinical trials of novel devices for percutaneous coronary and structural intervention, and manages the structural heart program based at the Palo Alto VA Hospital.
Associate Professor of Medicine (Pulmonary and Critical Care Medicine) at the Stanford University Medical Center
Current Research and Scholarly Interests 1. Development and evaluation of prognostic and diagnostic integral biomarkers in PAH.
2. Prevalence and Treatment of Insulin Resistance in PAH.
3. Role of inflammation and proteomic signature in PAH
4. Development of novel therapeutics (bench to bedside) including FK506 & Elastase Inhibition in PAH.
5. Assessment of Vasoreactivity (gain and loss) in pulmonary arterial hypertension
6. Assessment of microvascular function in PAH.
James L. Zehnder, M.D.
Professor of Pathology (Research) and of Medicine (Hematology) at the Stanford University Medical Center
Current Research and Scholarly Interests Our laboratory focuses on translational research in 2 main areas - genomic approaches to diagnosis and minimal residual disease testing for patients with cancer, and molecular basis of disorders of thrombosis and hemostasis. My clinical focus is in molecular pathology, diagnosis and treatment of disorders of hemostasis and thrombosis and general hematology.
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
Bio I am initially a Pittsburgh, PA native, but have been at Stanford University since 2012 for residency, fellowship, and now as faculty. It is exciting to be affiliated with one of the most dynamic and innovative medical institutions worldwide.
My clinical and research interests focus on functional, motility, and esophageal disorders of the gastrointestinal tract. Outside of this sub-sub specialization, a significant portion of my practice is also devoted to the care of a broad range of ?general gastroenterology? concerns.
Functional, motility, esophageal, and general gastroenterology disorders are very common, and can cause significant disability. Some examples include irritable bowel syndrome, functional dyspepsia, gastroparesis, chronic nausea, chronic constipation, achalasia, and gastroesophageal reflux disease.
Despite the common nature of these disorders, many are not well understood, leading to frustration among both patients and clinicians alike. Furthermore, there is an incorrect stigma associated with some of these disorders that ?it is all in your head.? On the opposite side of the spectrum, there is sometimes an incorrect assumption that we will be able to pinpoint an exact underlying cause in all cases, but this is not possible with current technology. We aim to bridge this gap using the latest diagnostic testing and treatment paradigms, as well as a healing hand. Additionally, our group is actively engaged in multiple research projects and studies to drive the future of the field.
Though I am early in my career, I am hoping that by the end the field will look nothing like it does today. I am hopeful, and I believe that we can revolutionize the field to better characterize gastrointestinal disorders, and come up with highly effective targeted treatments.
Professor of Medicine (Infectious Diseases) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly Interests Dr. Zolopa’s research applies a variety of clinical epidemiologic methods in an effort to optimize antiretroviral therapy and understand the impact of drug resistance on response to ARV. Areas of focus include the clinical application of resistance testing in optimizing antiretroviral therapy, clinical cohorts, trials of antiretroviral therapies and population-based epidemiologic evaluation of HIV resistance and efficacy of ARV therapy. More recently studies focused on premature aging in HIV.
Assistant Professor of Medicine (General Medical Disciplines)
Current Research and Scholarly Interests - Improving care and supporting self-management for patients with multiple chronic conditions
- Designing and evaluating innovative health care delivery models for complex and costly patients
- Optimizing health-related technology to personalize and improve care for complex patients and their caregivers